Cancer and Insulin-like Growth Factor-I. A Potential Mechanism Linking the Environment with Cancer Risk

Overview

Journal BMJ

Specialty General Medicine

Date 2000 Oct 6

PMID 11021847

Citations 23

Authors

G D Smith

D Gunnell

J Holly

Affiliations

Soon will be listed here.

Citing Articles

Protein Quantity and Source, Fasting-Mimicking Diets, and Longevity.

Brandhorst S, Longo V Adv Nutr. 2019; 10(Suppl_4):S340-S350.

PMID: 31728501 PMC: 6855936. DOI: 10.1093/advances/nmz079.

Fasting and Caloric Restriction in Cancer Prevention and Treatment.

Brandhorst S, Longo V Recent Results Cancer Res. 2016; 207:241-66.

PMID: 27557543 PMC: 7476366. DOI: 10.1007/978-3-319-42118-6_12.

Metabolic syndrome is associated with better prognosis in patients with tongue squamous cell carcinoma.

Zou L, Liu T, Yang A Chin J Cancer. 2015; 34(4):184-8.

PMID: 25963193 PMC: 4593369. DOI: 10.1186/s40880-015-0009-7.

Safety, tolerability, and pharmacokinetics of single and multiple doses of intravenous cixutumumab (IMC-A12), an inhibitor of the insulin-like growth factor-I receptor, administered weekly or every 2 weeks in patients with advanced solid tumors.

Higano C, Berlin J, Gordon M, Lorusso P, Tang S, Dontabhaktuni A Invest New Drugs. 2015; 33(2):450-62.

PMID: 25749986 DOI: 10.1007/s10637-015-0217-7.

Serum glucose and risk of cancer: a meta-analysis.

Crawley D, Holmberg L, Melvin J, Loda M, Chowdhury S, Rudman S BMC Cancer. 2014; 14:985.

PMID: 25526881 PMC: 4320469. DOI: 10.1186/1471-2407-14-985.

References

Jenkins P . Cancer in acromegaly. Trends Endocrinol Metab. 2008; 9(9):360-6. DOI: 10.1016/s1043-2760(98)00093-9. View

Dunn S, Kari F, French J, Leininger J, Travlos G, Wilson R . Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res. 1997; 57(21):4667-72. View

Lichtenstein P, Holm N, Verkasalo P, Iliadou A, Kaprio J, Koskenvuo M . Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000; 343(2):78-85. DOI: 10.1056/NEJM200007133430201. View

Juul A, Bang P, Hertel N, Main K, Dalgaard P, Jorgensen K . Serum insulin-like growth factor-I in 1030 healthy children, adolescents, and adults: relation to age, sex, stage of puberty, testicular size, and body mass index. J Clin Endocrinol Metab. 1994; 78(3):744-52. DOI: 10.1210/jcem.78.3.8126152. View

Chan J, Stampfer M, Giovannucci E, Gann P, Ma J, Wilkinson P . Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science. 1998; 279(5350):563-6. DOI: 10.1126/science.279.5350.563. View

Ma J, Pollak M, Giovannucci E, Chan J, Tao Y, Hennekens C . Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst. 1999; 91(7):620-5. DOI: 10.1093/jnci/91.7.620. View

Holly J, Gunnell D, Davey Smith G . Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer?. J Endocrinol. 1999; 162(3):321-30. DOI: 10.1677/joe.0.1620321. View

Wu X, Yu H, Amos C, Hong W, Spitz M . Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk. J Natl Cancer Inst. 2000; 92(9):737-43. DOI: 10.1093/jnci/92.9.737. View

Hankinson S, Willett W, Colditz G, Hunter D, Michaud D, Deroo B . Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet. 1998; 351(9113):1393-6. DOI: 10.1016/S0140-6736(97)10384-1. View

10.

Janssen J, Stolk R, Pols H, Grobbee D, Lamberts S . Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease. Arterioscler Thromb Vasc Biol. 1998; 18(2):277-82. DOI: 10.1161/01.atv.18.2.277. View

11.

Davey Smith G, Hart C, Upton M, Hole D, Gillis C, Watt G . Height and risk of death among men and women: aetiological implications of associations with cardiorespiratory disease and cancer mortality. J Epidemiol Community Health. 2000; 54(2):97-103. PMC: 1731616. DOI: 10.1136/jech.54.2.97. View

12.

Petridou E, Dessypris N, Spanos E, Mantzoros C, Skalkidou A, Kalmanti M . Insulin-like growth factor-I and binding protein-3 in relation to childhood leukaemia. Int J Cancer. 1999; 80(4):494-6. DOI: 10.1002/(sici)1097-0215(19990209)80:4<494::aid-ijc2>3.0.co;2-k. View

13.

Sacca L, Cittadini A, Fazio S . Growth hormone and the heart. Endocr Rev. 1994; 15(5):555-73. DOI: 10.1210/edrv-15-5-555. View

14.

Gunnell D . Height, insulin-like growth factors and cancer risk. Growth Horm IGF Res. 2000; 10 Suppl A:S39-40. DOI: 10.1016/s1096-6374(00)90019-4. View

15.

Frankel S, Gunnell D, Peters T, Maynard M, Davey Smith G . Childhood energy intake and adult mortality from cancer: the Boyd Orr Cohort Study. BMJ. 1998; 316(7130):499-504. PMC: 2665640. DOI: 10.1136/bmj.316.7130.499. View

16.

Djavan B, Bursa B, Seitz C, Soeregi G, Remzi M, Basharkhah A . Insulin-like growth factor 1 (IGF-1), IGF-1 density, and IGF-1/PSA ratio for prostate cancer detection. Urology. 1999; 54(4):603-6. DOI: 10.1016/s0090-4295(99)00280-0. View